Sovato has completed a Series B financing round to accelerate the development of its teleoperated robotic surgery system, ...

Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

Fintel reports that on November 6, 2025, Barclays maintained coverage of agilon health (NYSE:AGL) with a Underweight ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

Amgen on Tuesday reported quarterly financial results that beat Wall Street expectations, and raised its full-year outlook, ...

Get the latest on MindMed’s Q3 2025 earnings: clinical trial milestones, financial strength, and pivotal Phase III data readouts expected in 2026.

Investors are watching for private updates on the job market as the government shutdown is days away from becoming the ...

Amylyx now expects to complete recruitment for the LUCIDITY Phase III trial in Q1 2026 with top line data expected in Q3 2026, shifting both timelines by approximately one quarter from previous ...

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

The COLA boost is slightly better than earlier estimates, even if we're not talking about a lot of money. But many retirees ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ProQR ( (PRQR) ) has issued an ...

Meet some of the team behind UConn Health's effort to improve health care quality, address patient disparities with more REL ...